price
CR
NASDAQ · CRVS
Corvus Pharmaceuticals, Inc.
Healthcare · Biotechnology
$12.95
Down-$0.49 (-3.77%)
Updated Sep 16, 2026, 6:18 PM
SID Score
5.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 627.78M
- P/E ratio
- -46.21
- Dividend yield
- 0.00%
- 52-week range
- $5.64 – $26.95
- Volume
- 1.4M
- Avg. volume
- 1.02M
Price performance
CRVS price history
1M range · 20 trading sessions · Daily adjusted prices
CRVS closed at $12.95 after 20 trading sessions, down 12.68% for the selected period.
- Last close
- $12.95
- Period change
- -12.68%
- Period low
- $12.91
- Period high
- $15.40
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $13.07 | $13.17 | $12.45 | $12.95 | 1.4M |
| Sep 14, 2026 | $12.92 | $13.305 | $12.905 | $13.11 | 1.09M |
| Sep 11, 2026 | $13.13 | $13.495 | $12.7702 | $12.91 | 1.26M |
| Sep 10, 2026 | $13.06 | $13.135 | $12.82 | $12.94 | 1.09M |
| Sep 9, 2026 | $13.76 | $13.905 | $12.95 | $13.33 | 1.11M |
| Sep 8, 2026 | $14.01 | $14.32 | $13.85 | $13.93 | 1.03M |
| Sep 4, 2026 | $14.34 | $14.74 | $14.335 | $14.39 | 626.95K |
| Sep 3, 2026 | $14.38 | $14.715 | $13.98 | $14.65 | 938.43K |
| Sep 2, 2026 | $14.38 | $14.82 | $13.87 | $14.20 | 619.86K |
| Sep 1, 2026 | $13.86 | $14.30 | $13.84 | $14.27 | 460.17K |
| Aug 31, 2026 | $14.09 | $14.16 | $13.71 | $14.04 | 883.15K |
| Aug 28, 2026 | $14.60 | $14.60 | $13.975 | $14.16 | 644.53K |
| Aug 27, 2026 | $14.74 | $15.14 | $14.6228 | $14.72 | 508.07K |
| Aug 26, 2026 | $14.55 | $15.035 | $14.34 | $14.73 | 692.83K |
| Aug 25, 2026 | $14.30 | $14.83 | $14.30 | $14.56 | 642.26K |
| Aug 24, 2026 | $14.37 | $14.37 | $13.785 | $14.09 | 513.48K |
| Aug 21, 2026 | $14.52 | $14.7592 | $14.38 | $14.46 | 473.79K |
| Aug 20, 2026 | $15.15 | $15.311 | $14.14 | $14.33 | 783.58K |
| Aug 19, 2026 | $15.20 | $15.72 | $14.94 | $15.40 | 846.33K |
| Aug 18, 2026 | $14.75 | $15.14 | $14.61 | $14.83 | 635.37K |
Latest CRVS news
The latest Smart Investors Daily articles mentioning CRVS.
Stock researchResearch & News · Analysis
Loading stock research…

